» Articles » PMID: 39792832

Recent Advances in Strategies to Enhance Photodynamic and Photothermal Therapy Performance of Single-Component Organic Phototherapeutic Agents

Abstract

Photodynamic therapy (PDT) and photothermal therapy (PTT) have emerged as promising treatment options, showcasing immense potential in addressing both oncologic and nononcologic diseases. Single-component organic phototherapeutic agents (SCOPAs) offer advantages compared to inorganic or multicomponent nanomedicine, including better biosafety, lower toxicity, simpler synthesis, and enhanced reproducibility. Nonetheless, how to further improve the therapeutic effectiveness of SCOPAs remains a challenging research area. This review delves deeply into strategies to improve the performance of PDT or PTT by optimizing the structural design of SCOPAs. These strategies encompass augmenting reactive oxygen species (ROS) generation, mitigating oxygen dependence, elevating light absorption capacity, broadening the absorption region, and enhancing the photothermal conversion efficiency (PCE). Additionally, this review also underscores the ideal strategies for developing SCOPAs with balanced PDT and PTT. Furthermore, the potential synergies are highlighted between PDT and PTT with other treatment modalities such as ferroptosis, gas therapy, chemotherapy, and immunotherapy. By providing a comprehensive analysis of these strategies, this review aspires to serve as a valuable resource for clinicians and researchers, facilitating the wider application and advancement of SCOPAs-mediated PDT and PTT.

Citing Articles

Recent Advances in Strategies to Enhance Photodynamic and Photothermal Therapy Performance of Single-Component Organic Phototherapeutic Agents.

Fang L, Chen Z, Dai J, Pan Y, Tu Y, Meng Q Adv Sci (Weinh). 2025; 12(7):e2409157.

PMID: 39792832 PMC: 11831458. DOI: 10.1002/advs.202409157.

References
1.
Huang L, Zhou M, Abbas G, Li C, Cui M, Zhang X . A Cancer Cell Membrane-Derived Biomimetic Nanocarrier for Synergistic Photothermal/Gene Therapy by Efficient Delivery of CRISPR/Cas9 and Gold Nanorods. Adv Healthc Mater. 2022; 11(16):e2201038. DOI: 10.1002/adhm.202201038. View

2.
Xu C, Jiang Y, Han Y, Pu K, Zhang R . A Polymer Multicellular Nanoengager for Synergistic NIR-II Photothermal Immunotherapy. Adv Mater. 2021; 33(14):e2008061. DOI: 10.1002/adma.202008061. View

3.
Duan X, Zhang Q, Jiang Y, Wu X, Yue X, Geng Y . Semiconducting Polymer Nanoparticles with Intramolecular Motion-Induced Photothermy for Tumor Phototheranostics and Tooth Root Canal Therapy. Adv Mater. 2022; 34(17):e2200179. DOI: 10.1002/adma.202200179. View

4.
Li J, Dai J, Zhuang Z, Meng Z, Hu J, Lou X . Combining PD-L1 blockade with immunogenic cell death induced by AIE photosensitizer to improve antitumor immunity. Biomaterials. 2022; 291:121899. DOI: 10.1016/j.biomaterials.2022.121899. View

5.
Tavakkoli Yaraki M, Liu B, Tan Y . Emerging Strategies in Enhancing Singlet Oxygen Generation of Nano-Photosensitizers Toward Advanced Phototherapy. Nanomicro Lett. 2022; 14(1):123. PMC: 9072609. DOI: 10.1007/s40820-022-00856-y. View